EUROPA Sustained-Release Tablet 0.4 mg (Tamsulosin Hydrochloride)

Adult dose

Adults: Administer 0.4 mg of tamsulosin hydrochloride orally once daily after a meal. Swallow this medicine whole; do not crush or chew it.

This medication should not be used in certain patients. For example, it should not be administered to patients with allergies to this medication or its ingredients, patients with orthostatic hypotension due to sudden drops in blood pressure, patients with severe liver dysfunction, pregnant women or women who may become pregnant, and patients with lactose intolerance or certain genetic disorders of lactose metabolism. Additionally, patients with severely impaired kidney function, elderly patients, and patients taking certain antihypertensives, PDE5 inhibitors, or CYP3A4 inhibitors should exercise caution when using this medication. In particular, patients currently taking alpha-1 blockers or those with a history of urinary-related syncope should generally avoid this medication, or use it cautiously only if necessary. Side effects such as dizziness, headaches, dyspepsia, diarrhea, abdominal discomfort, and decreased semen volume may occur when taking this medication. Rarely, serious side effects such as hypotension or priapism may also develop, so the patient should consult a doctor immediately if symptoms occur. During treatment, blood pressure may drop suddenly, so movement should be slow when standing up, and caution is advised during potentially dangerous activities such as driving or operating machinery. Additionally, this medication alleviates symptoms but does not address the underlying cause of the condition; if symptoms do not improve, alternative treatment options should be considered. This medication may interact with certain drugs, so if the patient is currently taking any other medication, they must inform their doctor or pharmacist and seek advice. In particular, caution is necessary when used in conjunction with antihypertensives, PDE5 inhibitors, or CYP3A4 inhibitors. Women who are pregnant or breastfeeding, as well as children under 18 years of age, should not use this medication due to uncertainty regarding its safety and effectiveness. In elderly patients, especially those with severely impaired kidney function, the use of this medication is not recommended. Finally, this medication is a sustained-release preparation and should be swallowed whole, not chewed or crushed, to minimize the risk of esophageal injury. It should be stored out of the reach of children and should not be transferred to other containers.

• Abdominal discomfort
• upper abdominal pain
• dizziness
• diarrhea
• indigestion
• herpes zoster
• decreased semen volume
• headache
• vertigo
• eye pain

This medication should be stored in a tightly sealed container to prevent air or moisture from entering. It is advisable to maintain a storage temperature between 1 and 30 degrees Celsius.

Appearance

White round sustained-release film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle